| Dr Thomas Michael Leschke, MD | |
|
1000 N Oak Ave, Marshfield, WI 54449-5703 | |
| (920) 279-9835 | |
| Not Available |
| Full Name | Dr Thomas Michael Leschke |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 1000 N Oak Ave, Marshfield, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457730988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 66167 (Wisconsin) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 66167 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshfield Medical Center | Marshfield, WI | Hospital |
| Lakeview Medical Center Of Rice Lake | Rice lake, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mchs Hospitals Inc | 5698071173 | 1049 |
| Lakeview Medical Center Inc Of Rice Lake | 6103737820 | 131 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Beaver Dam Community Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972188555 PECOS PAC ID: 2567370539 Enrollment ID: O20040210000666 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20040519001426 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Flambeau Hospital, Inc. |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1700963048 PECOS PAC ID: 9032029871 Enrollment ID: O20070828000478 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Memorial Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20110526000807 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Lakeview Medical Center Inc Of Rice Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Entity Name | Flambeau Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194317966 PECOS PAC ID: 9032029871 Enrollment ID: O20210409000059 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Michael Leschke, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (920) 279-9835 | Dr Thomas Michael Leschke, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (920) 279-9835 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Even as the bipartisan measure, which would fund the federal government through the current fiscal year, progresses through Congress, the larger deficit debate continues as the parties move forward with starkly different fiscal blueprints.
A new study found that children who were bullied during P.E. class or other physical activities were less likely to participate in physical activity one year later.
Summer is preparing to make its debut in a few weeks, and along with it, most of us will flock to the outdoors to soak up sunshine and Vitamin D.
Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
› Verified 6 days ago
David J Simenstad, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
Thomas F Hitchcock, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
Kenneth D Stone, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-9227 | |
Tyler Jacob Dahl, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
John P Milbauer, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 613 Sycamore Ave, Marshfield, WI 54449 Phone: 715-387-6639 | |
Robert E Leggon, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5202 | |
Rachel M Randall, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 |